Final countdown! Submit your abstract before November 16th
November 11th, 2021
Daniela Lopez de Luise
|
|
|
3rd INTERNATIONAL CONFERENCE ON LYMPHOCYTE ENGINEERING |
|
31 March – 2 April | Munich, Germany |
|
|
|
|
|
|
|
|
|
LAST DAYS TO SUBMIT YOUR RESEARCH |
|
|
Are you working on your latest research? You have one more week to submit an abstract and present your clinical findings, therapies, or pipeline to a focused international audience.
Did you know that with 64 approved advanced therapy medicinal products (ATMPs) worldwide, the United States, by authorizing 20 ATMPs (11 CTMPs, 7 TEPs, and 2 GTMPs), is the pioneer country in this field? It is followed by South Korea with 15 ATMPs (13 CTMPs and 2 TEPs), the European Union with 9 ATMPs, and Iran with 6 ATMPs.
Make sure your country is represented during the in-person edition of ICLE 2022 on 31 March – 2 April 2022. Send us your important work today and put your country on the lymphocyte еngineering map!
|
|
|
|
Don’t miss this opportunity to advance your career and share your insights on CAR-T Cell and other lymphocyte engineering therapies at the cornerstone event in the field.
Accepted abstracts will be published in HGT Journal – the premier, multidisciplinary journal covering all aspects of gene therapy – HGT Journal.
Abstract Submission Deadline: 16 November 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
Both comments and pings are currently closed.